5 Followers on Owler

Lexeo

is a New York-based biotechnology company that researches and develops genetic medicine candidates for the treatment of cardiovascular and Alzheimer's diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Lexeo

is a New York-based biotechnology company that researches and develops genetic medicine candidates for the treatment of cardiovascular and Alzheimer's diseases... Read more
Lexeo CEO: R. Nolan Townsend

CEO

R. Nolan Townsend

CEO Approval Rating

90/100

2018

PublicNASDAQLXEO

Pharmaceuticals & Biotechnology
Biotechnology

Annual Revenue
$ < 1M
Employees
59
Funding
$613.8M
Acquisitions
1

News

Funding
Oct 21, 2025
GlobeNewswire
Lexeo received $10M in Private Placement Funding

Lexeo Competitors

1Sol­id Bio
2Prime Medicine
3Voyager
4Lacerta Therapeutics
5Neurocrine Biosciences
6Tune Therapeutics
7Larimar Therapeutics
8Design Therapeutics
9Biogen
10Tenaya
Unlock 7 + competitors

Trending Companies